Justin Sullivan/Getty Pictures Information
- Gilead (NASDAQ:GILD) desires vital worth hikes for a number of HIV medication broadly distributed by the state AIDS Drug Help Applications, a transfer that has precipitated issues amongst ADAP administrators, Stat Information reported on Tuesday.
- Throughout its discussions with the state ADAPs, the
